Literature DB >> 8863165

X chromosome inactivation pattern in female carriers of X linked hypophosphataemic rickets.

K H Orstavik1, R E Orstavik, J Halse, J Knudtzon.   

Abstract

X linked hypophosphataemia (XLH) results from an abnormality of renal tubular phosphate reabsorption. The disorder is inherited as an X linked dominant trait and the gene has been mapped to Xp22.1-p22.2. A candidate gene (PEX) has recently been isolated. The most striking clinical features are growth retardation and skeletal abnormalities. As expected for X linked dominant disorders, females are less affected. However, such a gene dosage effect does not exist for renal phosphate reabsorption. Preferential X chromosome inactivation has been proposed as a possible explanation for this lack of gene dosage. We have examined the X inactivation pattern in peripheral blood cells from 12 females belonging to seven families with XLH using PCR analysis at the androgen receptor locus. The X inactivation pattern in these patients did not differ significantly from the pattern in 30 healthy females. The X inactivation pattern in peripheral blood cells does not necessarily reflect the X inactivation pattern in renal cells. However, the finding of a normal distribution of X inactivation in peripheral blood cells indicates that the similarity in the renal handling of phosphate in male and female patients is not related to a ubiquitous preferential X inactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863165      PMCID: PMC1050707          DOI: 10.1136/jmg.33.8.700

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis of congenital hypophosphatemia.

Authors:  B G GREENBERG; R W WINTERS; J B GRAHAM
Journal:  J Clin Endocrinol Metab       Date:  1960-03       Impact factor: 5.958

2.  A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature.

Authors:  R W WINTERS; J B GRAHAM; T F WILLIAMS; V W McFALLS; C H BURNETT
Journal:  Medicine (Baltimore)       Date:  1958-05       Impact factor: 1.889

3.  X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults.

Authors:  I R Reid; D C Hardy; W A Murphy; S L Teitelbaum; M A Bergfeld; M P Whyte
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

4.  X-linked hypophosphatemia: the mutant gene is expressed in teeth as well as in kidney.

Authors:  E D Shields; C R Scriver; T Reade; T M Fujiwara; K Morgan; A Ciampi; S Schwartz
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

5.  Selection against lethal alleles in females heterozygous for incontinentia pigmenti.

Authors:  B R Migeon; J Axelman; S Jan de Beur; D Valle; G A Mitchell; K N Rosenbaum
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

6.  Non-random X chromosome inactivation in an affected twin in a monozygotic twin pair discordant for Wiedemann-Beckwith syndrome.

Authors:  R E Orstavik; N Tommerup; K Eiklid; K H Orstavik
Journal:  Am J Med Genet       Date:  1995-03-27

7.  Refining the genetic map for the region flanking the X-linked hypophosphataemic rickets locus (Xp22.1-22.2).

Authors:  P S Rowe; J Goulding; A Read; H Lehrach; F Francis; A Hanauer; C Oudet; V Biancalana; S W Kooh; K E Davies
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

8.  Carrier detection in the Wiskott Aldrich syndrome.

Authors:  E R Fearon; D B Kohn; J A Winkelstein; B Vogelstein; R M Blaese
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

Review 9.  X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage.

Authors:  C R Scriver; H S Tenenhouse
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

10.  Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells.

Authors:  B R Migeon; H W Moser; A B Moser; J Axelman; D Sillence; R A Norum
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

View more
  5 in total

Review 1.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

2.  X Chromosome Inactivation in Opioid Addicted Women.

Authors:  Nasim Vousooghi; Mitra-Sadat Sadat Shirazi; Ali Goodarzi; Peyman Hassani Abharian; Mohammad-Reza Zarrindast
Journal:  Basic Clin Neurosci       Date:  2015-07

Review 3.  Upstream Regulators of Fibroblast Growth Factor 23.

Authors:  Danielle M A Ratsma; M Carola Zillikens; Bram C J van der Eerden
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 5.555

4.  PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets.

Authors:  Hae Ryong Song; Joo Won Park; Dae Yeon Cho; Jae Hyuk Yang; Hye Ran Yoon; Sung Chul Jung
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

5.  X chromosome inactivation in carriers of Barth syndrome.

Authors:  K H Orstavik; R E Orstavik; A K Naumova; P D'Adamo; A Gedeon; P A Bolhuis; P G Barth; D Toniolo
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.